DERMPAT
ActiveSummary
DERMPAT has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €595,946 and a net result of €46,857. Equity is growing by ~18.5% per year across the filed fiscal years. Its solvency ranks better than 43% of 2356 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability74▼-14
Solvency77▼-10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45,000 at 30 days acceptable
Liquidity ample (current ratio 2.72 against 3.11 in 2024; short-term debt: 21.3% and cash: 20.5% of total assets), and 48.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
51.7%
Return on assets
4.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-05-2026, 72 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
72 d early
2024
121 d early
2023
92 d early
2022
61 d early
2021
67 d early
2020
25 d early
2019
25 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 66 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Turnover
€1.9m
EBIT margin
14.5%
Net result
€46,857▼ 74.6%
2024 · €184,668
Working capital
€422,043▼ 25.8%
2024 · €569,149
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€1.9m
Operating result€274,976▲ 30.3%€73,513▼ 73.3%€79,764▲ 8.5%€243,696▲ 206%€63,202▼ 74.1%
Net result€213,159within the sector's middle half▲ 11.6%€64,738within the sector's middle half▼ 69.6%€70,131within the sector's middle half▲ 8.3%€184,668within the sector's middle half▲ 163%€46,857within the sector's middle half▼ 74.6%
EBIT margin14.5%
Equity€515,231within the sector's middle half▲ 60.0%€556,969within the sector's middle half▲ 8.1%€599,109within the sector's middle half▲ 7.6%€744,352within the sector's middle half▲ 24.2%€595,946within the sector's middle half▼ 19.9%
Total assets€624,832within the sector's middle half▲ 4.3%€854,569within the sector's middle half▲ 36.8%€876,447within the sector's middle half▲ 2.6%€1.2mwithin the sector's middle half▲ 36.5%€1.2mwithin the sector's middle half▼ 3.7%
Debt€109,601▼ 60.4%€297,601▲ 172%€277,338▼ 6.8%€452,393▲ 63.1%€556,346▲ 23.0%
Working capital€220,468€454,368▲ 106%€420,105▼ 7.5%€569,149▲ 35.5%€422,043▼ 25.8%
Solvency82.5%above the sector's middle half▲ 28.7pp65.2%within the sector's middle half▼ 17.3pp68.4%within the sector's middle half▲ 3.2pp62.2%within the sector's middle half▼ 6.2pp51.7%within the sector's middle half▼ 10.5pp
Staff (FTE)6.3within the sector's middle half▲ 3.3%6.9within the sector's middle half▲ 9.5%7.9within the sector's middle half▲ 14.5%9.1above the sector's middle half▲ 15.2%11.4above the sector's middle half▲ 25.3%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 74% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.2m
Fixed assets
€484,478 ▲ 35.5%
Current assets
€667,814 ▼ 20.4%
Equity and liabilities €1.2m
Equity
€595,946 ▼ 19.9%
Debt
€556,346 ▲ 23.0%
Debt's share of the balance-sheet total rises from 37.8% to 48.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€244,331▼
2024 · €373,017
Cash flow
€227,987▼
2024 · €313,989
Current ratio
2.72▼
2024 · 3.11
Quick ratio
2.39▼
2024 · 2.82
Debt to equity
0.93▲
2024 · 0.61
ROE
7.9%▼
2024 · 24.8%
ROA
4.1%▼
2024 · 15.4%
Interest coverage
29.05▼
2024 · 182.17
Debt ≤ 1 year
€245,771▼
2024 · €269,926
Debt > 1 year
€189,915▲
2024 · €64,242
Income taxes
€8,840▼
2024 · €57,773
Staff costs
€793,263▲
2024 · €580,557
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,040 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 96% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit under 5% of the balance sheet
0.3%
went bankrupt
3.6%
stopped otherwise
96%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,040 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €1.9m | - | - | - | - | - |
| Non-recurring operating income76A | - | €4,525 | €400 | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | €1.2m | - | - | - | - | - |
| Remuneration, social security and pensions62 | €376,019 | €419,299 | €455,422 | €580,557 | €793,263 | ▲ 36.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €125,997 | €97,850 | €143,146 | €129,322 | €181,129 | ▲ 40.1% |
| Other operating charges640/8 | €3,940 | €887 | €2,654 | €5,152 | €15,696 | ▲ 205% |
| Gross operating margin9900 | €780,932 | €591,548 | €680,985 | €958,727 | €1.1m | ▲ 9.9% |
| Operating profit (loss)9901 | €274,976 | €73,513 | €79,764 | €243,696 | €63,202 | ▼ 74.1% |
| Financial income75/76B | €0 | - | €8 | €792 | €906 | ▲ 14.4% |
| Recurring financial income75 | €0 | - | €8 | €792 | €906 | ▲ 14.4% |
| Financial charges65/66B | €713 | €562 | €560 | €2,048 | €8,410 | ▲ 311% |
| Recurring financial charges65 | €713 | €562 | €560 | €2,048 | €8,410 | ▲ 311% |
| Profit (loss) for the period before taxes9903 | €274,263 | €72,951 | €79,212 | €242,440 | €55,697 | ▼ 77.0% |
| Income taxes67/77 | €61,104 | €8,213 | €9,081 | €57,773 | €8,840 | ▼ 84.7% |
| Profit (loss) for the period9904 | €213,159 | €64,738 | €70,131 | €184,668 | €46,857 | ▼ 74.6% |
| Profit (loss) for the period to be appropriated9905 | €213,159 | €64,738 | €70,131 | €184,668 | €46,857 | ▼ 74.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €624,832 | €854,569 | €876,447 | €1.2m | €1.2m | ▼ 3.7% |
| Fixed assets21/28 | €295,330 | €246,579 | €318,796 | €357,671 | €484,478 | ▲ 35.5% |
| Intangible fixed assets21 | €77,559 | €85,098 | €106,543 | €112,636 | €88,955 | ▼ 21.0% |
| Tangible fixed assets22/27 | €217,771 | €161,481 | €212,253 | €245,035 | €395,523 | ▲ 61.4% |
| Land and buildings22 | €99,141 | €79,412 | €70,080 | €52,527 | €33,223 | ▼ 36.8% |
| Plant, machinery and equipment23 | €97,970 | €75,796 | €136,960 | €106,611 | €86,848 | ▼ 18.5% |
| Furniture and vehicles24 | €10,726 | €6,273 | €5,214 | €3,968 | €3,442 | ▼ 13.3% |
| Leasing and similar rights25 | - | - | - | €81,929 | €272,012 | ▲ 232% |
| Other tangible fixed assets26 | €9,934 | - | - | - | - | - |
| Current assets29/58 | €329,502 | €607,990 | €557,650 | €839,075 | €667,814 | ▼ 20.4% |
| Stocks and contracts in progress3 | €34,084 | €63,137 | €60,878 | €77,971 | €80,927 | ▲ 3.8% |
| Stocks30/36 | €34,084 | €63,137 | €60,878 | €77,971 | €80,927 | ▲ 3.8% |
| Amounts receivable within one year40/41 | €264,147 | €225,134 | €368,242 | €296,752 | €319,976 | ▲ 7.8% |
| Trade receivables40 | €251,147 | €207,847 | €352,746 | €286,336 | €311,198 | ▲ 8.7% |
| Other amounts receivable41 | €13,000 | €17,287 | €15,496 | €10,416 | €8,778 | ▼ 15.7% |
| Current investments50/53 | - | - | - | €100,000 | - | - |
| Cash at bank and in hand54/58 | €24,483 | €306,025 | €109,127 | €311,112 | €236,515 | ▼ 24.0% |
| Deferred charges and accrued income490/1 | €6,787 | €13,695 | €19,403 | €53,240 | €30,396 | ▼ 42.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €624,832 | €854,569 | €876,447 | €1.2m | €1.2m | ▼ 3.7% |
| Equity10/15 | €515,231 | €556,969 | €599,109 | €744,352 | €595,946 | ▼ 19.9% |
| Contributions10/11 | €160,000 | €160,000 | €160,000 | €160,000 | €160,000 | = |
| Reserves13 | €353,500 | €395,000 | €435,000 | €580,000 | €430,000 | ▼ 25.9% |
| Non-distributable reserves130/1 | €16,000 | - | - | - | - | - |
| Reserves not available under the articles1311 | €16,000 | - | - | - | - | - |
| Distributable reserves133 | €337,500 | €395,000 | €435,000 | €580,000 | €430,000 | ▼ 25.9% |
| Profit (loss) carried forward14 | €1,731 | €1,969 | €4,109 | €4,352 | €5,946 | ▲ 36.6% |
| Amounts payable17/49 | €109,601 | €297,601 | €277,338 | €452,393 | €556,346 | ▲ 23.0% |
| Amounts payable after more than one year17 | - | - | - | €64,242 | €189,915 | ▲ 196% |
| Financial debts170/4 | - | - | - | €64,242 | €189,915 | ▲ 196% |
| Amounts payable within one year42/48 | €109,034 | €153,623 | €137,545 | €269,926 | €245,771 | ▼ 8.9% |
| Current portion of amounts payable after more than one year42 | - | - | - | €16,513 | €72,275 | ▲ 338% |
| Trade debts44 | €51,480 | €89,917 | €59,054 | €119,500 | €55,107 | ▼ 53.9% |
| Suppliers440/4 | €51,480 | €89,917 | €59,054 | €119,500 | €55,107 | ▼ 53.9% |
| Taxes, remuneration and social security45 | €37,554 | €40,706 | €50,500 | €94,488 | €73,125 | ▼ 22.6% |
| Taxes450/3 | €2,033 | €3,629 | €6,446 | €40,929 | - | - |
| Remuneration and social security454/9 | €35,522 | €37,077 | €44,054 | €53,559 | €73,125 | ▲ 36.5% |
| Other amounts payable47/48 | €20,000 | €23,000 | €27,991 | €39,424 | €45,264 | ▲ 14.8% |
| Accrued charges and deferred income492/3 | €567 | €143,978 | €139,793 | €118,225 | €120,661 | ▲ 2.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €213,159 | €64,738 | €70,131 | €184,668 | €46,857 | ▼ 74.6% |
| + Depreciation and write-downs630 | €125,997 | €97,850 | €143,146 | €129,322 | €181,129 | ▲ 40.1% |
| Operating cash flow (approximation) | €339,156 | €162,587 | €213,277 | €313,989 | €227,987 | ▼ 27.4% |
| Investment in fixed assets (approximation) | - | -€49,099 | -€215,363 | -€168,196 | -€307,937 | ▼ 83.1% |
| Change in cash | - | €281,542 | -€196,897 | €201,984 | -€74,596 | ▼ 137% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-05
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
01-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
30-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-05
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
25-05
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €213,159 ▲11.6%
Operating result €274,976, net result €213,159, both a record.
31-12
Financial
Liquidity triplescurrent ratio 3.02
Current ratio from 0.90 to 3.02; short-term debt falls from €276,836 to €109,034.
31-12
Financial
Equity above €500,000Eq €515,231 ▲60%
3 profitable years in a row build equity to €515,231.
06-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Equity above €200,000Eq €322,072 ▲103%
2 profitable years in a row build equity to €322,072.
06-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Back to profitnet €96,627
Net result €96,627 after one loss-making year.
Show earlier events
31-12
Financial
Equity above €150,000Eq €158,644 ▲114%
Equity rises from €74,091 to €158,644.
13-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 13 days late
2018
19-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
07-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 7 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2017
Ground area
222 m²
Building footprint
109 m²
Volume, LiDAR
1,527 m³
Parcel 44809I0793/00P004, Flanders · tallest building 17.2 m, ±5 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Laboratorium
since 20172.263.681.179
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44809I0793/00P004 | Flanders | 222 m² | 1 · 109 m² | 17.2 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
3 ownersOwners 3
-
33.35%
-
33.33%
-
33.33%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 5 entries · 814,997 EUR awarded · 219,718 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 810,229 EUR | 217,296 EUR |
| 2024 | 1 | 3,035 EUR | 1,439 EUR |
| 2023 | 1 | 0 EUR | 225 EUR |
| 2022 | 1 | 1,733 EUR | 758 EUR |
Similar companies · same sector, comparable size
Dokter S. VAN ERUM
BE 0461.185.015
Oostende · Eq €597,763
DR. M. STUBBE
BE 0842.501.022
Sint-Pieters-Leeuw · Eq €591,392
GHYVAN
BE 0825.766.938
Lochristi · Eq €601,358
CELL-CELL BIO
BE 0782.638.362
Gent · Eq €588,405
BODSON-FRANCOIS
BE 0892.646.260
Sprimont · Eq €604,061
Of 699 companies in sector 86910 we hold annual accounts for 521. 404 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded22-12-2011
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86910Medical imaging and medical laboratories
68203Renting and operating of own or leased non-residential real estate, excluding land
E-invoicing
Reachable via Peppol
Peppol ID
0208:0842445493
Registered
02-09-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.